IRIS Accounts Production v25.2.0.378 09600103 Board of Directors 1.6.24 31.12.24 31.12.24 true false true false false false true false Ordinary 0.10000 Ordinary A 0.10000 Ordinary B 0.10000 0.10000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096001032024-05-31096001032024-12-31096001032024-06-012024-12-31096001032023-05-31096001032023-06-012024-05-31096001032024-05-3109600103ns15:EnglandWales2024-06-012024-12-3109600103ns14:PoundSterling2024-06-012024-12-3109600103ns10:Director12024-06-012024-12-3109600103ns10:PrivateLimitedCompanyLtd2024-06-012024-12-3109600103ns10:SmallEntities2024-06-012024-12-3109600103ns10:AuditExempt-NoAccountantsReport2024-06-012024-12-3109600103ns10:SmallCompaniesRegimeForAccounts2024-06-012024-12-3109600103ns10:FullAccounts2024-06-012024-12-310960010312024-06-012024-12-3109600103ns10:OrdinaryShareClass12024-06-012024-12-3109600103ns10:OrdinaryShareClass22024-06-012024-12-3109600103ns10:OrdinaryShareClass32024-06-012024-12-31096001031ns10:OrdinaryShareClass12024-06-012024-12-3109600103ns10:Director22024-06-012024-12-3109600103ns10:RegisteredOffice2024-06-012024-12-3109600103ns5:CurrentFinancialInstruments2024-12-3109600103ns5:CurrentFinancialInstruments2024-05-3109600103ns5:Non-currentFinancialInstruments2024-12-3109600103ns5:Non-currentFinancialInstruments2024-05-3109600103ns5:ShareCapital2024-12-3109600103ns5:ShareCapital2024-05-3109600103ns5:RetainedEarningsAccumulatedLosses2024-12-3109600103ns5:RetainedEarningsAccumulatedLosses2024-05-3109600103ns5:PatentsTrademarksLicencesConcessionsSimilar2024-06-012024-12-3109600103ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-06-012024-12-3109600103ns5:ShortLeaseholdAssetsns5:LandBuildings2024-06-012024-12-3109600103ns5:PatentsTrademarksLicencesConcessionsSimilar2024-05-3109600103ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-05-3109600103ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3109600103ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3109600103ns5:PatentsTrademarksLicencesConcessionsSimilar2024-05-3109600103ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-05-3109600103ns5:ShortLeaseholdAssetsns5:LandBuildings2024-05-3109600103ns5:ShortLeaseholdAssetsns5:LandBuildings2024-12-3109600103ns5:ShortLeaseholdAssetsns5:LandBuildings2024-05-3109600103ns5:CostValuation2024-05-3109600103ns5:AdditionsToInvestments2024-12-3109600103ns5:DisposalsRepaymentsInvestments2024-12-3109600103ns5:CostValuation2024-12-3109600103ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3109600103ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3109600103ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-12-3109600103ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-05-3109600103ns10:OrdinaryShareClass12024-12-3109600103ns10:OrdinaryShareClass22024-12-3109600103ns10:OrdinaryShareClass32024-12-3109600103ns5:RetainedEarningsAccumulatedLosses2024-05-3109600103ns5:RetainedEarningsAccumulatedLosses2024-06-012024-12-31
REGISTERED NUMBER: 09600103 (England and Wales)












AGRIBIOTECH INTERNATIONAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024






AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


AGRIBIOTECH INTERNATIONAL LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024







DIRECTORS: Mr R Calcagni
Mr G Calcagni





REGISTERED OFFICE: Sterling House
Fulbourne Road
Walthamstow
London
E17 4EE





REGISTERED NUMBER: 09600103 (England and Wales)





ACCOUNTANTS: Christiansons Ltd
Chartered Certified Accountants
Sterling House
Fulbourne Road
Walthamstow
London
E17 4EE

AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.5.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 180,478 208,243
Tangible assets 5 92,060 108,307
Investments 6 2,784,420 2,313,209
3,056,958 2,629,759

CURRENT ASSETS
Stocks 7 52,692 175,000
Debtors 8 1,699,397 2,360,440
Cash at bank and in hand 32,288 22,112
1,784,377 2,557,552
CREDITORS
Amounts falling due within one year 9 583,054 1,604,956
NET CURRENT ASSETS 1,201,323 952,596
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,258,281

3,582,355

CREDITORS
Amounts falling due after more than one
year

10

-

1,425,038
NET ASSETS 4,258,281 2,157,317

CAPITAL AND RESERVES
Called up share capital 11 5,200,000 2,500,000
Retained earnings 12 (941,719 ) (342,683 )
SHAREHOLDERS' FUNDS 4,258,281 2,157,317

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





Mr G Calcagni - Director


AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024


1. STATUTORY INFORMATION

Agribiotech International Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Know how and licences
Know how and licences is amortised over the estimated life of the asset of eight years.

Development costs
Development costs is amortised over the estimated life of the asset of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Buildings and structures - 15% on reducing balance

Investments in subsidiaries and associates
Investments in subsidiary and associate undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2024 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Development
Know how costs Totals
£    £    £   
COST
At 1 June 2024
and 31 December 2024 73,145 314,676 387,821
AMORTISATION
At 1 June 2024 73,145 106,433 179,578
Amortisation for period - 27,765 27,765
At 31 December 2024 73,145 134,198 207,343
NET BOOK VALUE
At 31 December 2024 - 180,478 180,478
At 31 May 2024 - 208,243 208,243

5. TANGIBLE FIXED ASSETS
Buildings
and
structures
£   
COST
At 1 June 2024
and 31 December 2024 265,289
DEPRECIATION
At 1 June 2024 156,982
Charge for period 16,247
At 31 December 2024 173,229
NET BOOK VALUE
At 31 December 2024 92,060
At 31 May 2024 108,307

AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024


6. FIXED ASSET INVESTMENTS

31.12.24 31.5.24
£    £   
Shares in group undertakings 2,018,849 1,695,482
Participating interests 290,454 290,455
Other investments not loans 475,117 327,272
2,784,420 2,313,209

Additional information is as follows:
Shares in Interest Interest
group in joint in
undertakings venture associate Totals
£    £    £    £   
COST
At 1 June 2024 1,695,482 290,454 1 1,985,937
Additions 323,367 - - 323,367
Disposals - - (1 ) (1 )
At 31 December 2024 2,018,849 290,454 - 2,309,303
NET BOOK VALUE
At 31 December 2024 2,018,849 290,454 - 2,309,303
At 31 May 2024 1,695,482 290,454 1 1,985,937

Investments (neither listed nor unlisted) were as follows:
31.12.24 31.5.24
£    £   
Orchards Cost/valuation 327,272 327,272
Orchards Addition 147,845 -
475,117 327,272

7. STOCKS
31.12.24 31.5.24
£    £   
Stocks 52,692 175,000

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.5.24
£    £   
Trade debtors 576,150 259,519
Amounts owed by group undertakings 953,055 2,100,877
Other debtors 72 44
Prepayments and accrued income 170,120 -
1,699,397 2,360,440

AGRIBIOTECH INTERNATIONAL LIMITED (REGISTERED NUMBER: 09600103)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JUNE 2024 TO 31 DECEMBER 2024


9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.5.24
£    £   
Trade creditors 223,510 223,477
Directors' current accounts 358,004 1,378,529
Accruals and deferred income 1,540 2,950
583,054 1,604,956

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.24 31.5.24
£    £   
Other loans - 1-2 years - 1,425,038

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.5.24
value: £    £   
47,000,000 Ordinary 10p 4,700,000 2,000,000
3,500,000 Ordinary A 10p 350,000 350,000
1,500,000 Ordinary B 10p 150,000 150,000
5,200,000 2,500,000

The following shares were issued during the period for cash at par :

27,000,000 Ordinary shares of 10p

12. RESERVES
Retained
earnings
£   

At 1 June 2024 (342,683 )
Deficit for the period (599,036 )
At 31 December 2024 (941,719 )